MENU

BLU BELLUS Health Forecast, Technical & Fundamental Analysis

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL343.461.46
+0.43%
Apple
BTC.X81500.805000-640.656250
-0.78%
Bitcoin cryptocurrency
SPY763.25-8.54
-1.11%
State Street SPDR S&P 500 ETF (SPY)
TSLA354.72-7.72
-2.13%
Tesla
GME26.81-1.21
-4.32%
GameStop Corp
A.I. Advisor
published General Information

General Information

a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs

Industry Biotechnology

Industry
N/A
Address
275 Armand-Frappier Boulevard
Phone
+1 450 680-4500
Employees
74
Web
http://www.bellushealth.com
BELLUS Health (BLU) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com